RSS

Vabomere

The US Food and Drug Administration (FDA) has approved an antibacterial drug, Vabomere, for the treatment of adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. more

News